Kirat Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Rohini New Delhi, Delhi, India, established in 2012.
2012 Rohini New Delhi, Delhi, India Struck Off
Last Updated:
About Kirat Pharmaceuticals Private Limited

Kirat Pharmaceuticals Private Limited, a struck off private limited company, was established on 19 November 2012 in Rohini New Delhi, Delhi, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232DL2012PTC245026. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Ramratan (Director), Subhash Chander (Director). Past directors included Ankit Goyal, Naveen Kumar, Ashish Agarwal. It is based at House No-140 Block H Pocket 3 Sector-16, Rohini New Delhi, Delhi, 110085.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2012PTC245026

  • Registration Number

    245026

  • Incorporation Date

    19 November 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 2 Months
Company report

Kirat Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kirat Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kirat Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Ramratan Director 11 Dec 2014 Current
Subhash Chander Director 12 Dec 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Dec 2014 Past
Pramod Abcsdd Director 12 Dec 2014 Past
Pramod Abcsdd Director 12 Dec 2014 Past
Pramod Abcsdd Director 23 Nov 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kirat Pharmaceuticals.

Enhance accessibility to Kirat Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Kirat Pharmaceuticals revenue growth over time
Kirat Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kirat Pharmaceuticals?

Unlock access to Kirat Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kirat Pharmaceuticals?

Unlock and access historical data on people associated with Kirat Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kirat Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kirat Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kirat Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Subhash Chander was appointed as a Director was appointed as a Director on 12 Dec 2014 & has been associated with this company since 11 years 2 months . was recorded as a recent event.

  • Director Appointment

    Progress on Ramratan was appointed as a Director was appointed as a Director on 11 Dec 2014 & has been associated with this company since 11 years 2 months . was documented.

  • Company Incorporation

    The activity Kirat Pharmaceuticals Private Limited was registered on 19 Nov 2012 with Roc Delhi & aged 13 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kirat Pharmaceuticals Private Limited?

The CIN of Kirat Pharmaceuticals Private Limited is U24232DL2012PTC245026.

Where is Kirat Pharmaceuticals Private Limited headquartered?

Kirat Pharmaceuticals Private Limited is headquartered at House No-140 Block H Pocket 3 Sector-16, Rohini New Delhi, Delhi, 110085.

When was Kirat Pharmaceuticals Private Limited incorporated?

Kirat Pharmaceuticals Private Limited was incorporated on 19 November 2012.

Who are the current directors of Kirat Pharmaceuticals Private Limited?

The current directors of Kirat Pharmaceuticals Private Limited are

What is the primary industry of Kirat Pharmaceuticals Private Limited?

The primary industry of Kirat Pharmaceuticals Private Limited is Chemicals.

Is Kirat Pharmaceuticals Private Limited a listed company?

Kirat Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Kirat Pharmaceuticals Private Limited?

The authorized capital of Kirat Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available